Skip to main content
. Author manuscript; available in PMC: 2012 Mar 15.
Published in final edited form as: J Am Coll Cardiol. 2011 Mar 15;57(11):1314–1322. doi: 10.1016/j.jacc.2011.01.011

Table 2.

Lesion Characteristics

BMS (197 lesions) DES
P value BMS vs. DES (SES + PES)
All (SES + PES) (209 lesions) SES (103 lesions) PES (106 lesions)
Stent duration, days 721 (271, 1801) 361 (172, 540) 361 (180, 541) 270 (149, 473) <0.001
Indication of stent implantation
 Stable angina pectoris 150 (76) 150 (72) 72 (70) 78 (74) 0.316
 Unstable angina pectoris/AMI 47 (24) 59 (28) 31 (30) 28 (26)
Lesion location
 Vessel: Left main coronary artery 4 (2) 6 (3) 2 (2) 4 (4) 0.501
  Left anterior descending 73 (37) 87 (42) 41 (40) 46 (43)
  Left circumflex 45 (23) 51 (24) 24 (23) 27 (26)
  Right coronary artery 75 (38) 65 (31) 36 (35) 29 (27)
 Proximal lesion 77/161 (48) 102/202 (51) 45/98 (46) 57/104 (55) 0.613
 Mid/Distal lesion 84/161 (52) 100/202 (49) 53/98 (54) 47/104 (45)
Stent length, mm 16.0 (12.0, 24.0) 22.0 (15.5, 30.0) 21.0 (15.0, 30.0) 22.0 (15.8, 30.3) <0.001
Overlapping stents 36 (18) 63 (30) 30 (29) 33 (31) 0.005
Underlying plaque morphology
 Ruptured plaque/TCFA 26 (13) 49 (23) 28 (27) 21 (20) 0.008
 Fibroatheroma 86 (44) 104 (50) 44 (43) 60 (57) 0.261
 Fibrocalcific 29 (15) 16 (7) 8 (8) 8 (7) 0.023
 Pathologic intimal thickening 47 (24) 20 (10) 13 (12) 7 (7) <0.001
 Others* 9 (4) 20 (10) 10 (10) 10 (9) 0.051

Values are expressed as medians (interquartile range) or n (%).

*

“Others” includes underlying restenotic lesion, calcified nodule, and dissection.

AMI = acute myocardial infarction, BMS = bare metal stents, DES = drug-eluting stents, PES = paclitaxel-eluting stents, SES = sirolimus-eluting stents, TCFA = thin-cap fibroatheroma